Thank you for your patience over the last two weeks!
An unusual April has wrapped, but May has gotten off to an unsettling start, from the stock market to telehealth’s leaders such as Teladoc. Hot areas like telemental health and prescribing are (deservedly) under scrutiny, and Noom’s losing more than pounds. But a sign of normality is that ATA is back in person, and there were many announcements with significance.
Weekend news and deals roundup: Allscripts closes sale of hospital EHRs, closing out CEO; DEA scrutiny of Cerebral’s ADHD telehealth prescribing; more telehealth fraud; Noom lays off; fundings; and why healthcare AI is only ML (Looks like some cleaning up is going on)
ATA conference roundup: a new board chair, a digital app review pilot, and company announcements (Hopkins study, BioIntelliSense, Connect America, AliveCor, Withings, more)
Some thoughts on Teladoc and the Week That Was in telehealth (When the whales are in trouble, there may be opportunities for the minnows)
April is proving to be an active month for something other than rain and blooming cherry trees. A new CEO for Tunstall. Tivity and MobileHelp are sold. UnitedHealth and Optum won’t give up on Change, including a hefty break fee, nor big buys. On the retail front, Walmart finally opens up Florida superstores powered by Epic, and Walgreens ‘corners’ with Blue Shield in California. Some local telehealth grants and the surprising vitality of audio telehealth for the underserved. And, to no one’s surprise, digital health got off to a slow start in Q1.
Tunstall Healthcare announces new group CEO, Emil Peters (More changing of the guard)
Weekend roundup: telehealth claims ticked up again in January, Walmart opens Florida health ‘superstores’, Blue Shield California partners with Walgreens’ Health Corners
Thursday roundup: UHG/Optum, Change extend merger deadline to 31 Dec, buys Kelsey-Seybold; $2B Tivity Health sale; General Dynamics enters derm AI diagnostics; MobileHelp PERS sold to Advocate Aurora (A recovery in the works?)
Digital health funding’s Q1 hangover from 2021’s bender–and Q2 is a question mark, even for Rock Health (Some companies have aching heads still)
Wisconsin’s $5M for child psychiatry, community telehealth; FQHC patients prefer audio-only telehealth–Rand (Back to the roots of telehealth for less health served populations)
Have a job to fill? Seeking a position? See jobs listed with our new job search partner Jooble in the right sidebar!
The first full week of Spring turned out to be a busy one, from big buys by UHG/Optum in home and mental health, a significant one by LetsGetChecked, and more health tech fundings. Babylon’s Higi integrates their chatbot. Optum’s physician telehealth study shows there’s a way to go, along with Laurie Orlov’s aging tech studies and articles. The former Practice Fusion’s miseries with DOJ continue. And Amazon Health’s looking for talent.
Weekend wrapup & reading: Amazon Health on talent hunt, Practice Fusion fined $200K for violating $145M prosecution agreement, and must-read studies and articles on older adults tech (Read in between spring cleaning)
What do physicians really think about telehealth, now that they’ve used it? Lower use, substantial frustrations remain. (Another needle puncturing the bubble)
Friday roundup: LetsGetChecked buys Veritas Genetics, Everly Health adds CMO, Babylon sends chatbot to Higi, ConcertAI’s $150M Series C, AmplifyMD’s $23M, and two ‘Brights’ raise $155M (Reviving market?)
UnitedHealth Group makes two jumbo buys for Optum: LHC Group home health for $5B, Refresh Mental Health (Optum not letting grass grow with the Change DOJ lawsuit)
Winter turned into Spring, it’s raining, and it’s time for pleasant thoughts of a cheerful movie about the Umbrellas of Cherbourg. Speaking of France, Glooko’s European tour picked up DIABNEXT. Action in Asia-Pac with Vietnam’s Jio Health and Pear for sleepless Japanese. Certainly Sunny Balwani isn’t getting much sleep lately with the kickoff of Theranos Trial #2. And after 25 years of one man at the top, it’s a young tech-savvy woman in charge at Centene–and their cubies are hanging on.
Short takes for Thursday: TimeDoc’s timely $48M, Glooko buys France’s DIABNEXT, Jio Health’s $20M, Pear’s Tokyo sleep-wake, Antidote’s $22M, and Centene’s new, young CEO signals big changes (More consolidation, funding, and a changing of the guard after 25 years)
The Theranos Trials, ch. 3: Sunny and Elizabeth were in it together, all the way (Balwani’s rerun of Holmes’ trial)
DOJ lawsuit to block UnitedHealth-Change Healthcare’s acquisition now set for 1 August trial (UHG and Change not giving up)
Read Telehealth and Telecare Aware: https://telecareaware.com/ @telecareaware
We thank our present and past advertisers and supporters: Legrand/Tynetec, Eldercare, UK Telehealthcare, NYeC, PCHAlliance, ATA, The King’s Fund, DHACA, HIMSS, Health 2.0 NYC, MedStartr, Parks Associates, and HealthIMPACT.
Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach.
Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine, and health tech, worldwide–thoughtfully and from the view of fellow professionals
Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know.
Donna Cusano, Editor In Chief
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –